"Nuclear medicines, like radioligand therapy, could be transformative for cancer care in Australia. Establishing clear pathways for market access and a thriving nuclear medicine industry will be key to enabling Australian patients to access these new treatment options," said Novartis country president Matt Zeller. …
New Novartis-backed report identifies nuclear medicine opportunity but calls for change
April 19, 2024 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
'Unfortunately, there remain significant gaps in knowledge among healthcare professionals when it comes to menopause'
February 10, 2025 - - Latest News -
Historical change on pharmacy prescribing could be a sign of more to come
February 10, 2025 - - Latest News -
Sigma upgrades guidance as it prepares for Chemist Warehouse merger
February 10, 2025 - - Latest News -
Victorian official appointed to HTA Review implementation advisory group
February 10, 2025 - - Latest News -
First-time policy breakthrough with pharmacies to write PBS prescriptions
February 9, 2025 - - Latest News -
GSK out to an early lead in Rare Cancers Australia Kosi Challenge 'Pharma Cup'
February 7, 2025 - - Latest News -
'In an optimal, equitable system, access to evidence-based, cost-effective genomics-guided medicines would be provided to all'
February 7, 2025 - - Latest News